The Utility of Speckle Tracking Echocardiographic Parameters in Predicting Atrial Fibrillation Recurrence After

Decai Zeng1, Linyan Li1, Shuai Chang1

  • 1Department of Ultrasonic Medicine, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.

Insights

Speckle tracking echocardiography (STE) can predict atrial fibrillation (AF) recurrence after catheter ablation (CA) in non-valvular AF (NVAF) patients. Left atrial stiffness and LA reservoir strain (LASr) are key indicators for risk stratification and guiding follow-up care.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Echocardiography

Background:

  • Catheter ablation (CA) is effective for non-valvular atrial fibrillation (NVAF), but recurrence remains a challenge.
  • Predicting recurrence is crucial for optimizing patient management and follow-up strategies.

Purpose of the Study:

  • To assess the predictive value of speckle tracking echocardiographic (STE) parameters for AF recurrence post-CA.
  • To identify specific STE-derived metrics that can stratify risk in NVAF patients undergoing ablation.

Main Methods:

  • Prospective study of 380 NVAF patients undergoing CA.
  • Baseline left atrial (LA) function assessed using STE within 48 hours pre-ablation.
  • Follow-up for a median of 9 months to record AF recurrence.

Main Results:

  • Patients with AF recurrence had lower LA reservoir strain (LASr) and higher LA stiffness compared to the non-recurrence group.
  • Multivariable analysis identified LA stiffness and LASr as independent predictors of AF recurrence.
  • LA stiffness and LASr demonstrated superior predictive performance for 1- and 2-year AF recurrence compared to other parameters.

Conclusions:

  • STE-based evaluation of LA function aids in risk stratification for AF recurrence in NVAF patients post-CA.
  • LA stiffness and LASr are significant independent predictors of AF recurrence, potentially outperforming traditional morphological parameters.
  • These findings can guide personalized follow-up management for NVAF patients after ablation.
Abstract